Literature DB >> 22789135

Renal function and genetic polymorphisms in pediatric heart transplant recipients.

Brian Feingold1, Maria M Brooks, Adriana Zeevi, Erin L Ohmann, Gilbert J Burckart, Robert E Ferrell, Richard Chinnock, Charles Canter, Linda Addonizio, Daniel Bernstein, James K Kirklin, David C Naftel, Steven A Webber.   

Abstract

BACKGROUND: Common genetic variations influence rejection, infection, drug metabolism, and side effect profiles after pediatric heart transplantation. Reports in adults suggest that genetic background may influence post-transplant renal function. In this multicenter study, we investigated the association of genetic polymorphisms (GPs) in a panel of candidate genes on renal function in 453 pediatric heart transplant recipients.
METHODS: We performed genotyping for functional GPs in 19 candidate genes. Renal function was determined annually after transplantation by calculation of the estimated glomerular filtration rate (eGFR). Mixed-effects and Cox proportional hazard models were used to assess recipient characteristics and the effect of GPs on longitudinal eGFR and time to eGFR < 60 mL/min/1.73m(2).
RESULTS: Mean age at transplantation was 6.2 ± 6.1 years. Mean follow-up was 5.1 ± 2.5 years. Older age at transplant and black race were independently associated with post-transplant renal dysfunction. Univariate analyses showed FASL (C-843T) T allele (p = 0.014) and HO-1 (A326G) G allele (p = 0.0017) were associated with decreased renal function. After adjusting for age and race, these associations were attenuated (FASL, p = 0.075; HO-1, p = 0.053). We found no associations of other GPs with post-transplant renal function, including GPs in TGFβ1, CYP3A5, ABCB1, and ACE.
CONCLUSIONS: In this multicenter, large, sample of pediatric heart transplant recipients, we found no strong associations between GPs in 19 candidate genes and post-transplant renal function. Our findings contradict reported associations of CYP3A5 and TGFβ1 with renal function and suggest that genotyping for these GPs will not facilitate individualized immunosuppression for the purpose of protecting renal function after pediatric heart transplantation.
Copyright © 2012 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22789135      PMCID: PMC3428223          DOI: 10.1016/j.healun.2012.05.010

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  33 in total

1.  High prevalence of chronic kidney disease in pediatric solid organ transplantation.

Authors:  Guido Filler; Ajay P Sharma
Journal:  Pediatr Transplant       Date:  2008-11-01

2.  Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study.

Authors:  Diana M Girnita; Maria M Brooks; Steven A Webber; Gilbert J Burckart; Robert Ferrell; Gina Zdanowicz; Susan DeCroo; Louise Smith; Richard Chinnock; Charles Canter; Linda Addonizio; Daniel Bernstein; James K Kirklin; Sarangarajan Ranganathan; David Naftel; Alin L Girnita; Adriana Zeevi
Journal:  Transplantation       Date:  2008-06-15       Impact factor: 4.939

3.  Lessons learned from the pediatric heart transplant study.

Authors:  Daphne T Hsu; David C Naftel; Steven A Webber; William R Morrow; Charles E Canter; Richard E Chinnock; Mary Lynne Clark; James K Kirklin
Journal:  Congenit Heart Dis       Date:  2006-05       Impact factor: 2.007

4.  The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantation.

Authors:  Jacqueline van de Wetering; Charlotte H E Weimar; Aggie H M M Balk; Joke I Roodnat; Cécile T J Holweg; Carla C Baan; Ron T van Domburg; Willem Weimar
Journal:  Transplantation       Date:  2006-12-27       Impact factor: 4.939

5.  Effect of MDR1 gene polymorphism on progression of end-stage renal disease.

Authors:  Wei-xia Zhang; Bing Chen; Wen Zhang; Nan Chen; Zi-cheng Yu; Wei-min Cai
Journal:  Acta Pharmacol Sin       Date:  2007-04       Impact factor: 6.150

6.  Impact of TGFbeta1 gene polymorphisms on late renal function in pediatric heart transplantation.

Authors:  Sylvie Di Filippo; Adriana Zeevi; Kevin K McDade; Gerard J Boyle; Susan A Miller; Sanjiv K Gandhi; Steven A Webber
Journal:  Hum Immunol       Date:  2005-02       Impact factor: 2.850

7.  No association between single nucleotide polymorphisms and the development of nephrotoxicity after orthotopic heart transplantation.

Authors:  Bärbel Klauke; Andreas Wirth; Armin Zittermann; Birte Bohms; Gero Tenderich; Reiner Körfer; Hendrik Milting
Journal:  J Heart Lung Transplant       Date:  2008-05-23       Impact factor: 10.247

8.  The profile of renal function over time in a cohort of pediatric heart transplant recipients.

Authors:  Winston Bharat; Cedric Manlhiot; Brian W McCrindle; Stacey Pollock-BarZiv; Anne I Dipchand
Journal:  Pediatr Transplant       Date:  2007-12-18

9.  Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: a 10-year national cohort study.

Authors:  Caroline K Lee; Laura L Christensen; John C Magee; Akinlolu O Ojo; William E Harmon; Nancy D Bridges
Journal:  J Heart Lung Transplant       Date:  2007-05       Impact factor: 10.247

10.  Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies.

Authors:  Santiago Rodriguez; Tom R Gaunt; Ian N M Day
Journal:  Am J Epidemiol       Date:  2009-01-06       Impact factor: 4.897

View more
  1 in total

1.  Cardiovascular health in pediatric heart transplant patients.

Authors:  Carmel Bogle; Amanda Marma Perak; Sarah J Wilkens; Alaa Aljiffry; Karen Rychlik; John M Costello; Donald M Lloyd-Jones; Elfriede Pahl
Journal:  BMC Cardiovasc Disord       Date:  2022-04-01       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.